A major advance in cancer investigation is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This crucial malignant protector protein is frequently inactivated in several types of cancer, https://socialtechnet.com/story7550037/mini-antibodies-reactivate-tumor-suppressor-p53-the-promising-approach-for-cancer-treatment